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Modulation of ornithine decarboxylase (ODC) gene expres-
sion by retinoids was analyzed in human keratinocyte cul-
tures maintained in serum-free medium containing 0.15 mM 
Ca++. Cells were incubated with all-trallS-retinoic acid, 13-
cis-retinoic acid or arotinoid Ro 15-0778 (10-10 to lO-s M), 
total RNA was isolated, and mRNA transcripts for ODC 
were analyzed by Northern and slot blot hybridizations with 
a human ODC eDNA. Treatment of cells for 24 h resulted in 
a dose-dependent decrease in ODC mRNA levels, with an 
estimated ICso of -I X 10-8 M for a11-trans- and 13-cis-reti-
noic acid, while RoI5-0778 was somewhat less effective 
(ICso -1-5 X 10- 7 M). The suppression of ODC mRNA 
levels by retinoids was detectable at -3 h of incubation, with 
RetinOids :ne powerful therapeutic agents that have been lIsed either systemically or to ically to treat a number of dermatologic disorders [t f In proliferating normal keratinocytes. retinoids cause an arrest of cell growth in a yredifferentiated state [2.3]. This growth 
suppression may be centra to their therapeutic effects in hypeIfro-
liferative epidermal disorders, such as psoriasis and ichthyosis 11]. 
A number of model systems have been used to measure the effi-
cacy of retinoids. These include the ability to induce differentiation 
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mRNA: messenger RNA 
ODC: ornithine decarboxylase 
RA: aJl-rratls-retinoic acid 
SDS: sodium dodecyl sulfate 
t X SSC: 0.15 M NaCI. 15 mM sodium citr.I.tt:, pH 6.8 
essentially a maximal inhibition at 12 h. Reduced ODC 
mRNA levels noted after 24 h of inc ubat ion with 5 X 10-7 M 
all-tram-retinoic acid were accompanied by' a reduction in 
ODC enzyme activity. To determine if all-trans-retinoic acid 
was regulating ODC gene expression directly, or if protein 
synthesis was required, ODe expression was analyzed in 
cultures treated with protein synthesis inhibitors. In the pres-
ence of cycloheximide or puromycin, all-tralls-retinoic acid 
did not suppress ODC mRNA levels. These findings suggest 
that suppression of ODe gene expression is not a direct effect 
of all-trans-retinoic acid, but depends on ongoing protein 
synthesis.] Invest D" .. atoI94:33-36, 1990 
ofF9 embryonal carcinoma cells 14], and to inhibit ODe activity in 
mouse skin after tape stripping [5 . ODe is the first and, app:uently, 
the rate-limiting enzyme in the biosynthesis of the polyamines. 
substances implicated in ma~y cellular process~s, such ~s transcrip-
tional and translational effiCiency [6]. There IS a reqUitement for 
polyamines for cell growth [7). ODC has one of the shortest half-
lives of known mammalian enzymes (tl /2 - 8 - 12 mm In mouse 
kidney [8]), and the enzyme responds to a variety of hormones and 
trophic stimuli with a rapid induction of activity (see. e.g., [9,10]). 
Therefore, changes in ODe activity occur raridly and have been 
well correlated with the growth state of cells 11]. 
In order to further understand the mechanism of inhibition of 
epidermal ODe activity by retinoids. we have examined their ef-
fects on ODe mRNA levels in cultured human epidermal keratino-
cytes, specifically, the effecrs of aH-traru-retinoic acid, 13-cis-reti-
noic acid, and Ro 15-0778. All three retinoids caused a 
dose-dependent suppression of ODe mRNA levels. and this effect 
could be abolished by inhibition of protein synthesis. 
MATERIALS AND METHODS 
Reagents All-tram-retinoic acid and 13-dr-retinoic acid were 
purchased from Sigma Chemical Co. (St. Louis, MO). RotS-0778 
was the kind gift of Dr, Stanley Shapiro (Hoffman-LaRoche. Nut-
ley, NJ), All rctinoids were stored at -20°C in the dark and dis-
solved in DMSO (Fisher Scientific, Philadelphia, PAl immediately 
before use. All other reagents were obtained from Sigma or Fisher. 
Cell C ultures Normal human epidermal keratinocytes were pur-
chased from Clonctics Corp. (San Diego, CAl at passage 2, and were 
grown, with daily medium changes. in medium containing 0.15 
mM Ca++ (KGM, Clonetics Corp.), supplemented with 50 J1g/ ml 
bovine pituitary extract [12] , Experimenrs were performed on cell 
cultures (passage 5) in mid-to-Iate log phase of growth. The reti-
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noid. or vehicle ([DMSO] s 0.1 %). was added to culture medium A 
in the dark. 
RNA Isolation, Northern Hybridizations, and Slot Blots 
RNA was isolated using the guanidinium isothiocyanate/cesium 
chloride method {l3.14]. For Northern hybridization {lSl. total 
RNA was fractionated on 1 % agarose gels containing 2.2 M (ormal-
dehyde. transferred to nitrocellulose. and hybridized with the 
human ODe eDNA. pODe 1O/2H [16] or with human p-.ctin 
cDNA [171. which were labeled by nick translation with 
a["P jdeTP fl8J. For ,lot blots. ,erial dilutions of total RNA were 
immobilized on nitrocellulose and hybridized with the 32P_labcled 
cDNA,. All blots were washed in 0.1 X sse. 0.1% SDS. at 6S·e 
for 30 min. The filters were exposed with DuPont Cronex film at 
-70·C. and mRNA levels were quantitated using a He-Nc laser 
del1Sitometer at 633 nm (LKll. Bromma. Sweden). The results were 
expressed as densitometric units (U) per .ug RNA. 
OD e Activity Cells were trypsinized. collected by centrifuga-
tion. and washed in phosphate-buffered saline. Cytosols were pre-
pared by lysing the cells with three freeze/thaw cycles. followed by 
centrifugation at 150.000 X g for 30 min at 4 ·e. ODCactivity was 
measured using the .4COz-release assay as described by Seely and 
Pegg 119]' Activiries were expressed as cpm/mg cymsolic protein/h 
at 37·C. Background HCOZ release was detennined using cy[Osol 
in the presence of 5 mM a-difluoromethylomithine (a-DFMO). 
Cytosolic protein was determined using the Bio-Rad Protein Assay 
kit. 
RESULTS 
To compare the effects of all-trotlS-rerinoic acid. 13-cis-r~tinoic acid, 
and Ro 15-0778 on ODC mRNA levels, subconfluent proliferating 
keratinocytes were treated with 10-10 to 10-5 M retinoid for 24 h 
(Fig t). Total RNA was isolated by the guanidiniulll isocltiocyan-
ate/C,CI[13.14J method and ODC mRNA levels determined by 
Northern blotting [15] and slot blot hybridi7_:lrinn with rhe human 
ODC cDNA (161. A dose-dependent decrease in ODC mRNA 
levels was observed with all three rcrinoids tested. AlI-trotlS- and 
13-cis-retinoic acid produced qualitatively similar dose-response 
curves and were approximately ten-fold more potent at suppressing 
ODC mRNA levelsthan Ro1S-0778 (IC .. -I X 10-' M for 13-,;,-
and all-trolls-rt"tinoic acid; ICse -1-5 X 10-1 M for Ro15-0778). 
The same Northerns were re-probed with {J-acrin cDNA 117] to 
insure that equal amounts of RNA were used in rhe different experi-
ments. No change in p-actin hybridization signal was measured 
berween the different incubation conditions indicating that the sup-
pression ofODC mRNA was due to a specific effect of the retinoids 
(data not shown). 
The time course of suppression of ODe mRNA levels was mea-
sured using 5 X 10- 7 M all-tratlS-rctinoicacid over 48-h (Fig 2). No 
change was measured after I h of treatment; however, a significant 
decrease in ODC mRNA levels was observed at 3 h. with the sup-
pression being essentially complete by 12 h (Fig 2B). 
To correlate the changes observed in ODC mRNA with changes 
in ODC activity, evolution of '·COz from [HC J ornithine 1181 was 
measured in extracts from keratinocytes that had been treated With 
DMSO (sO.l%, conrrol) or 5 X 10-7 M all-trolu-retinoic acid dis-
solved in DMSO for 0 and 24 h. Comrols at 0 and 24 h showed no 
significant difference in ODC activities, whereas kcratinocytes 
treated with all-cralls-rerinoic acid for 24 h contained approximarely 
30% of the ODe activi,), of the control cells (Table I). 
We then asked if the rcrinoids were causing the observed sup-
pression of ODe mRNA levels directly, or if prorein synthesis was 
necessary for rhis effect, by using the protein synthesis inhibitors, 
cycloheximide and puromycin. Keratinocytes, pre-incubated with 
10pg/tnl cycloheximide for I h and then labeled with ['H]leucine 
in (he presence of cycloheximide for 6 h, showed a greater than 95% 
decrease in protein synthesis (data not shown). Therefore. prolifer-
ating keratlnocytes were pre-incubated with 10 ,ug/ml cyclohexi-
mide. and then exposed to 5 X 10-7 M all-trons-retinoic acid, in rhe 
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Figure 1. Dosc~dependenr suppression of ODe mRNA levels as a function 
of rcc-iuoid concentrations. Norm:lil hum:lin keraunocytes were incubared for 
24 h With the indicated concentrations of (A) all-frdns-rerinoic :licid (opt71 
md~s) or 13~(is-retinoic acid (solid eirclfi), or (8) Ro 15-0778. ODe mRNA 
levels were determined by slot blot hybridizations :lIld ql1antified by scan-
ning densitometry. Control cultures received vehicle alone. The values are 
111e.a.n ± SO of three par:lillel cultures, each assayed using fivC' different RNA 
concencrations in two separate experiments. 
pared to DMSO-treated cultures containing cycloheximide (Fig 3). 
As shown above, treatment of keratinocytes with 5 X 10-7 M ail-
tralls-retinok acid caused a decrease in ODC mRNA levels. How-
ever, this decrease was not observed when cycloheximide was used 
in conjunction with retinoic acid treatment (Fig 3A,8). In fact. 
treatment of keratinocytes with cycloheximide caused an approxi-
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Figure 2. Tune course of suppression of ODe mRNA leve ls by all- trll nJ'-
rennoic acid. Kerarinocytes were treated with 5 X 10-7 M all-trllns-retinoic 
acid for the indicated tImes. ODe mRNA levels, shown as slot blot hybridi-
zarions of dilutions (A) were q uantilled by densitometry and expressed as 
percent of control (B). The values in Dare me:ln ± SO of Ilve parallel 
deternunants. 
Ill:m:ly twofold increase in ODe mRNA levels over comrol. To 
insure that any effects noted in the presence of cycloheximide were 
due to its inhibition of protein synthesis, keratinocytes were also 
treated with 50 ,tig/ml puromycin or 50 ,tig/ ml puromycin plus 
5 X 10- 7 M all-tralls- reeinoic acid. Like cycloheximide, puromycin 
blocked the suppress ion cfODC mRNA levels by retinoic acid and, 
when used alone, caused a small increase in ODe mRNA concen· 
tration (Fig 38). 
Table I. Effect of All-Trans-Retinoic Acid on ODC Activity in 
Human Keratinocytes 
DOC activity (cptn/m g protein) 
Control. 0 h 9980.6 ± 3040.3 (9)' 
Control. 24 It 12332.4 ± 3352.0 (9) 
5 X 10- 7 M all-mms-retinoic 3725.0 ± 1240.5 (10) 
acid. 24 h 
5 mM a-DFMO' 847.4 ± 453.0 (15) 
----------------------~~--
• V~lucs shown arc mc~n ± SO de:Ie:lTI1lne:d rrom fWO 5c:p.:il'2te: expenme:nts. The 
numlx-r or flasks ~lili~ye:d is indiotc:d III parellfhesc:s. 
• CylOsols were: I1Icubatcd 11\ the presence of 5 mM Q-OFMO to detenmnt' back· 
ground '·C02 release. 
RETINOID SU PPRESSION O F ODe 3S 
DISCUSSION 
Changes in ODC activity follow~d by changes in polyamine levels 
have been shown to accurately reflect the proliferativ~ state of many 
cell types ft tJ. In F9 embryonal carcinoma cel ls. retinoic acid in-
duce, differentiation [4,20,21] and suppresses ODe activity [221. 
Inhibition of ODe by the suicide inhibitora-DFMO is also capable 
of causing F9 cells to differentiate [231. It was ther~fore concluded 
that polyamines must be present in F9 cells above a minimum coo-
c~ntration . or the cells will differentiate. However, other di£feren-
tiation signals appear to function independcntly of polyamine con-
centration [21]. 
In this study. we asked if rctinoic ac id caused suppression of ODe 
mRNA levels in cultured human kcratinocytes and whether this 
suppression was a direct effect of retinoic acid or whethcr an inter-














Figure 3. Effect of protein synthesis inhibitors on suppressio n of ODC 
tnRNA levrls by all-trllns-retinoic acid. (A) Keratinocytes were pre.treated 
With 10 Jlg/ tnl cyclohexi mide followed by a 6-h treatment with 10 Jlg/ ml 
cyclohex imide (CHX) .and/or 5 X 10-' M .all -trll "s-rerinotc .acid (RA) as 
Indicated. ODC mRNA levels were detenmned by slo t blot hybridizations. 
(8) Keratinocytes were treated with vehicle alone (Iant l)i pre-treated for 1 
h. followed by a 6-h treatment with 10 J.lg/ ml cyclohex imide (101ft 2); 
pre-treated for I h, followed by a 6-h treatment wuh 50 J.lg/ml puromycin 
(Io"r J) ; tre.ated for 6 h with 5 X 10- 1 M all-trll lls-retinoic acid (lanI4); 
pre-treated fo r I h with 10 Jlg/tnl cycloheximide followed by treatment for 
6 h with 10 J.lg/ tnl cyclohexi mide and 5 X 10- 7 M all-trIHis-retinoic acid 
(10111 5); or pre-treated for 1 h with 50 J.lg/ml puromycin, fo ll owed by 
treatment for 6 h with 50 Jig/ml puromycin and 5 X 10- 7 M .all-trans-reti-
noic acid (la"l 6) . ODe mRNA levels were visu.alized by N orthern blot 
hybridization. 
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inoie acid, 13-cis-rctinoic acid, and Ro15-0778 cause a rapid. dose-
dependent decrease in ODe mRNA levels. 
Furthermore, no decrease in ODe mRNA is seen in the absence 
of protein synrhesis. However, since cycloheximide alone causes a 
cwofold increase in ODe III RNA levels. rhe role of protein synthe-
sis in the suppression of ODe mRN A levels by rcrinoids is not clear. 
For example. if cycloheximide suppresses the synthesis of a pcmein 
which mediates ODe mRNA turnover, the inhibition of rhe syn-
thesis of chis protein by cycloheximide would result in the stabiliza-
tion of ODe mRNA even if rcrinoids had directly suppressed ODe 
mRNA synthesis. 
Cycloheximide h:15 been found to affect ODe mRNA levels in 
other cell types. For example, in BC,HI muscle cells, cycloheximide 
caused an increase in steady-state ODe mRNA levels and in ODC 
gene transcription. However, no changes in ODe mRNA half-life, 
which has been estimated to be 6-8 h [24J, were detected [25J. 
Anisornycin also caused increases in ODe mRNA neady-state 
levels and in ODC gene transcription in BalbJc-3T3cells and in the 
pheochromocytoma cell line PC12 [26J, although the,e e!fects 
were small. These results, therefore, suggest that it is unlikely that 
either changes in mRNA half-life or gene transcription rates due to 
protein synthesis inhibition could account for the lack of response of 
ODC mRNA levels [0 retinoic acid in the presence of cyclohexi-
mide. 
Recently , deThc et al r271 have reported that retinoic acid in-
creases transcription of the p-retinoic acid recepcor gene. This in-
duction results in an accumulation of the p-retinoic acid receptor. a 
fonn of the receptor implicated in retinoic acid action in the skin 
[28,291. If this amplification mechanism functions in human kerati-
nocytes. then it is possible chat increased retinoic acid receptor levels 
arc mcdiating suppression of ODe gene expression. The suppres-
sion would therefore he dependent on new protein synthesis. We 
are currently exploring this possibility. 
The data we have presented in this paper demonstrate that reti-
noie acid suppresses ODe activity in keratinocytes by decreasing 
ODe mRNA levels and thus the amount of enzyme synthesized. 
Since protein synrhesis is required for this inhibition, these data are 
consistent with the hypothesis that retinok acid suppresses ODC 
mRNA levels through an intermediate protein. 
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